Xcovery, Inc. - Product Pipeline Review - H2 2011
Global Markets Direct
November 28, 2011 22 Pages - SKU: GMD6692720
|
|
Xcovery, Inc. - Product Pipeline Review - H2 2011
Summary
Global Market Direct’s pharmaceuticals report, “Xcovery, Inc. - Product Pipeline Review - H2 2011” provides data on the Xcovery, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Xcovery, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Xcovery, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope - Xcovery, Inc. - Brief Xcovery, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Xcovery, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Xcovery, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Xcovery, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy - Evaluate Xcovery, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Xcovery, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Xcovery, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Xcovery, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Xcovery, Inc. and identify potential opportunities in those areas.
|
- Xcovery, Inc. Snapshot
- Xcovery, Inc. Overview
- Key Information
- Key Facts
- Xcovery, Inc. - Research and Development Overview
- Key Therapeutic Areas
- Xcovery, Inc. - Pipeline Review
- Pipeline Products by Stage of Development
- Xcovery, Inc. - Pipeline Products Glance
- Xcovery, Inc.-Early Stage Pipeline Products
- Pre-Clinical Products/Combination Treatment Modalities
- Discovery Products/Combination Treatment Modalities
- Xcovery, Inc. - Drug Profiles
- PI3Kalpha Program
- Product Description
- Mechanism of Action
- R&D Progress
- PI3Kbeta Program
- Product Description
- Mechanism of Action
- R&D Progress
- X-339
- Product Description
- Mechanism of Action
- R&D Progress
- X-379
- Product Description
- Mechanism of Action
- R&D Progress
- X-480
- Product Description
- Mechanism of Action
- R&D Progress
- Xcovery, Inc. - Pipeline Analysis
- Xcovery, Inc. - Pipeline Products by Therapeutic Class
- Xcovery, Inc. - Pipeline Products By Target
- Xcovery, Inc. - Pipeline Products by Route of Administration
- Xcovery, Inc. - Pipeline Products by Molecule Type
- Xcovery, Inc. - Dormant Projects
- Xcovery, Inc. - Locations And Subsidiaries
- Head Office
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Xcovery, Inc. - Pipeline by Therapy Area and Indication, H2 2011
- Xcovery, Inc. - Pipeline by Stage of Development, H2 2011
- Xcovery, Inc. - Pipeline By Therapeutic Class, H2 2011
- Xcovery, Inc. - Pipeline By Target, H2 2011
- Xcovery, Inc. - Pipeline By Route of Administration, H2 2011
- Xcovery, Inc. - Pipeline By Molecule Type, H2 2011
- Xcovery, Inc. - Dormant Developmental Projects, 2010
- List of Figures
- Xcovery, Inc. - Pipeline by Therapy Area and Indication, H2 2011
- Xcovery, Inc. - Pipeline by Stage of Development, H2 2011
- Xcovery, Inc. - Pipeline By Therapeutic Class, H2 2011
- Xcovery, Inc. - Pipeline By Target, H2 2011
Share this report
Other tasks Related Markets Pharmaceuticals Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
